No Hearing: The Supreme Court yesterday rejected an appeal from insurers and other payers who said they paid too much for Eli Lilly’s antipsychotic drug Zyprexa because the drug company misrepresented the benefits of the medication, the WSJ reports . A lower court had ruled that there wasn’t a sufficient link between the high prices and Lilly’s marketing practices; the Supreme Court won’t hear a challenge to that ruling. Hospice Questions: There are concerns that commercial hospices are seeking out patients with better prognoses in an attempt to boost income, Kaiser Health News and the New York Times report . The inspector general of HHS is looking at “unusual patterns of hospice stays,” while whistleblower lawsuits have alleged efforts to keep patients in hospice as long as possible. Bond

Deal: Amgen sold $3 billion in debt in its second-biggest deal on record, Dow Jones Newswires reports . The proceeds of the sale will be used for general corporate purposes; Bloomberg News notes that could include share buybacks and quarterly dividends. Salmonella Alert: The FDA is warning consumers not to eat Evergreen Produce brand alfalfa or spicy sprouts because they are “possibly linked” to 20 cases of salmonella. The Idaho-based company has temporarily halted production of the sprouts but tells the Spokesman-Review in Spokane, Wa., that the agency “has not offered one bit of concrete evidence that we have a problem,” and that local consumers haven’t fallen ill. Image: iStockphoto

Go here to see the original: 
A.M. Vitals: Supreme Court Won’t Hear Appeal in Lilly Case